Sign In
Get Clay Free →

Suggestions

    Nina Leksa

    Distinguished Scientist and Group Head at Sanofi, Hemophilia and Musculoskeletal Disease Research Cluster

    Nina Leksa is a Distinguished Scientist and Group Head at Sanofi, specializing in hemophilia and musculoskeletal disease research.35 She has extensive experience in drug discovery and development for rare blood disorders, particularly bleeding disorders.3 Leksa holds a PhD and completed her graduate studies at MIT's Schwartz Lab.1 Her expertise includes protein biochemistry, protein structure, and drug development for rare blood disorders.

    At Sanofi, Leksa leads research efforts in the Immunology & Inflammation Therapeutic Area, based in Cambridge, MA.2 She has contributed to the development of SAR443809, a selective inhibitor of the complement alternative pathway, which has potential applications in treating complement-mediated disorders.2

    Prior to her current role, Leksa has held positions such as Senior Principal Scientist and Lab Head at Sanofi.4 Her career trajectory demonstrates a strong commitment to advancing treatments for rare diseases, particularly in the field of hematology and musculoskeletal disorders.

    Highlights

    SAR443809: a selective inhibitor of the complement alternative ...
    Jan 10 · calendar.mit.edu
    How to Carve Your Path in the Biopharmaceutical Industry
    Sanofi: Principal Scientist/Lab Head, Rare Musculoskeletal Disease ...
    Sanofi: Principal Scientist/Lab Head, Rare Musculoskeletal Disease ...

    Related Questions

    What are Nina Leksa's main research interests?
    How did Nina Leksa transition from a graduate student to a Distinguished Scientist at Sanofi?
    What are some notable projects Nina Leksa has led at Sanofi?
    What is Nina Leksa's educational background?
    How has Nina Leksa contributed to the field of immunology and inflammation?
    Nina Leksa
    Nina Leksa, photo 1
    Nina Leksa, photo 2
    Add to my network

    Location

    Greater Boston